Amedisys board of directors authorizes $100 million stock repurchase program

Baton rouge, la., dec. 23, 2020 (globe newswire) -- amedisys, inc. (nasdaq: amed), america's leading independent home health, hospice and personal care company, today announced that its board of directors has authorized a stock repurchase program, under which the company may repurchase up to $100 million of its outstanding common stock through december 31, 2021.

AMED Ratings Summary

AMED Quant Ranking